(Q24241874)

5

0 references

Andrew Jull

object named as

Andrew B Jull

1

0 references

author name string

Derrick A Bennett

3

0 references

Christel AE Dunshea-Mooij

Cochrane Database of Systematic Reviews

4

0 references

publication date

16 July 2008

0 references

published in

0 references

cites work

Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Randomized, double-blind trial of chitosan for body weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

A double-blind, placebo-controlled evaluation of the effects of RW94 on the body weight of both overweight and obese healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Chitosan Supplementation and Fecal Fat Excretion in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Chitosan supplementation and fat absorption in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Comparative evaluation of fecal fat excretion induced by orlistat and chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Human enzymatic activities related to the therapeutic administration of chitin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Alternative treatments for weight loss: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Modern medical management of obesity: the role of pharmaceutical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Overweight as an avoidable cause of cancer in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Use of nonprescription weight loss products: results from a multistate survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Body mass index and associations of sodium and potassium with blood pressure in INTERSALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Selected major risk factors and global and regional burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Impact of weight loss on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Obesity and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Chitosan functional properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Changes in patterns of fatness in adult men in relation to serum indices of cardiovascular risk: the Normative Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

Clinical and biochemical evaluation of chitosan for hypercholesterolemia and overweight control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

The treatment and prevention of obesity: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Chitosan supplementation does not affect fat absorption in healthy males fed a high-fat diet, a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

1 reference

7 January 2021

A novel use of chitosan as a hypocholesterolemic agent in rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Chitosan for weight loss and cholesterol management.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Effect of chitosan on renal function in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Compliance of the respiratory system and its components in health and obesity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Decrease in serum LDL cholesterol with microcrystalline chitosan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

Effect of Dietary Chitin on Cholesterol Absorption and Metabolism in Rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021

The effectiveness of popular, non-prescription weight loss supplements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003892.PUB3

7 January 2021